Smoking in New Zealand
In New Zealand, smoking is legal but subject to tobacco control regulations. Cigarettes are regulated as tobacco products and can be sold through retail outlets, including online sales and vending machines. The importation of cigarettes for trade is allowed with a trade license. Health warnings on packaging are mandatory, the legal minimum age for purchase is 18 years, and smoking in public places is subject to legal restrictions. A comprehensive ban on tobacco advertising is also in place. Cigarettes in New Zealand are taxed at a total rate of 82.78%, including an excise component of 69.74%. Data show that in 2024, the number of current smokers was recorded to be approximately 364,000 in New Zealand, corresponding to an adult smoking prevalence of 8.6%. In the same year, current smoking prevalence was slightly higher among males (9.7%) than among females (7.7%). In 2022, this prevalence was recorded to be 11.4%. In 2023, the adult daily tobacco smoking prevalence was reported to be 7.7%, with approximately 362,845 daily smokers. In 2021, smoking led to approximately 3,580 deaths in New Zealand, including 2,085 deaths among males and 1,495 deaths among females. In other words, tobacco smoking accounted for 10.38% of all deaths in the country in 2021, including11.78% of all male deaths and 8.9% of all female deaths.
Read articles from New Zealand
November 19, 2026 by nzherald.co.nz
Smoking rate falls below 6% for first time, daily vaping declines slightly
New Zealand's daily smoking rate has fallen below 6% for the first time, reaching 5.9% in the latest national health survey, down from 6.7% the previous year. Daily vaping also declined slightly, from 11.7% to 11.2%.
The figures mark continued progress in reducing cigarette use, although smoking rates remain considerably higher among Māori and Pacific communities.
New Zealand's experience highlights the importance of maintaining effective cessation support and access to lower-risk nicotine alternatives, while addressing persistent inequalities in smoking-related harm.
November 18, 2026 by acsh.org
Vaping and lung cancer: Here's what we know (and what we don't)
The long-term relationship between vaping and lung cancer remains uncertain, but existing evidence provides important distinctions between e-cigarettes and combustible tobacco.
Research shows that switching completely from smoking to vaping substantially reduces exposure to carcinogenic chemicals, including tobacco-specific nitrosamines. However, decades of follow-up are still needed to establish long-term cancer risks.
The findings reinforce the importance of distinguishing reduced toxicant exposure from proven reductions in disease risk, while recognising the potential role of vaping in tobacco harm reduction.
November 16, 2026 by substack.com
The Double Standard Behind the “False Promise”
The debate over nicotine pouches in New Zealand has exposed an important double standard in tobacco control research.
While critics demand stronger evidence that pouches support smoking cessation, the potential consequences of restricting access receive considerably less scrutiny. Existing research remains limited, but uncertainty about the benefits of nicotine pouches does not establish that prohibition produces better public health outcomes.
A balanced approach should apply the same scientific standards to both harm reduction interventions and restrictive policies, measuring success through actual changes in smoking behaviour and health outcomes.
November 05, 2026 by yonkerstimes.com
Vapes and Quitting Smoking: The Facts May Surprise You
Nicotine vaping can help adults quit smoking, but successful tobacco harm reduction involves more than simply replacing one product with another.
Clinical evidence supports e-cigarettes as a smoking cessation option, particularly for adults who struggle with traditional methods. Complete switching is important, as continued cigarette use alongside vaping may limit the potential health benefits.
Although long-term uncertainties remain, clear information about relative risk, personalised cessation support and realistic quitting plans can help smokers make informed decisions and move away from combustible tobacco.
November 05, 2026 by yonkerstimes.com
Vapes and Quitting Smoking: The Facts May Surprise You
Nicotine vaping can help adults quit smoking, but successful tobacco harm reduction involves more than simply replacing one product with another.
Clinical evidence supports e-cigarettes as a smoking cessation option, particularly for adults who struggle with traditional methods. Complete switching is important, as continued cigarette use alongside vaping may limit the potential health benefits.
Although long-term uncertainties remain, clear information about relative risk, personalised cessation support and realistic quitting plans can help smokers make informed decisions and move away from combustible tobacco.
October 29, 2026 by substack.com
When Listening Becomes Another Way to Lecture
Interviews with 20 illicit tobacco users in New Zealand reveal how financial hardship, nicotine dependence and frustration with tobacco policies influence purchasing decisions.
The findings raise questions about whether public health campaigns focused on changing consumer attitudes adequately address the economic pressures driving illicit sales.
Effective tobacco control should consider affordability, taxation and access to cessation support, including lower-risk nicotine alternatives. Understanding consumers' experiences is essential to developing policies that reduce smoking-related harm rather than reinforce existing barriers.
October 14, 2026 by planetofthevapes.co.uk
CAPHRA Welcomes Oz Proposal
CAPHRA welcomes an Australian opposition proposal to legalise and regulate adult access to vapes and nicotine pouches without prescriptions, but warns against linking it to an 80% cigarette excise cut. The package includes $200 million for enforcement and is projected to raise $8 billion over four years. Australia’s government rejects the proposal, while public health groups warn cheaper cigarettes could increase smoking. CAPHRA argues regulated alternatives—not cheaper cigarettes—would address illicit markets, citing New Zealand’s declining smoking rates since vaping regulation. It urges Canberra to assess legalisation separately from the contentious cigarette tax debate.
October 12, 2026 by gfn.tv
Why New Zealand Is Getting It Right?
New Zealand’s progress shows what tobacco policy can look like when harm reduction is treated as part of the solution. Smoking has fallen alongside access to vaping, suggesting that lower-risk alternatives can help accelerate the move away from combustion when smokers are given practical options. The lesson is not that regulation should disappear, but that it should support the direction of change already reducing harm. Public health should learn from countries where smoking is falling fastest, not dismiss the tools helping make it happen.
October 07, 2026 by substack.com
When Public Health Declares Itself Innocent
Public health loses authority when it treats disagreement as a threat rather than a test of its own claims. In nicotine policy, declaring one position beyond challenge can shut out evidence on relative risk, consumer behaviour and the unintended effects of restriction. Confidence is not the same as accountability. Institutions earn trust by showing their reasoning, correcting errors and allowing policy to be questioned when real-world outcomes do not match the promise.
October 05, 2026 by junonews.com
Op-Ed: The Tobacco Endgame
Ian Irvine argues that Canada’s restrictions on nicotine pouches undermine smoking cessation by making lower-risk alternatives harder to buy than cigarettes. He criticizes the Ontario Tobacco Research Unit’s opposition to nicotine substitution, advocating harm reduction rather than eliminating all nicotine use. Citing vaping initiatives in New Zealand and the UK, alongside declining smoking rates in Sweden and Norway, he urges Ottawa to improve access to pouches, vapes and heated tobacco products. Although nicotine causes dependence, Irvine maintains that these alternatives pose substantially lower health risks than smoking. The article discloses that some of his research received tobacco-policy foundation funding and that nicotine producers covered conference expenses.
- Page 1 of 24